A novel link between SUMO modification and cancer metastasis
1Department of Biological Sciences, Research Center for Functional Cellulomics, Seoul National University, Seoul 151-742, South Korea. sbaek@snu.ac.kr
Cell Cycle (Georgetown, Tex.)
|July 25, 2006
Summary
Small ubiquitin-related modifier (SUMO)ylation impacts cancer metastasis by regulating chromatin remodeling complexes. SUMOylation of the reptin complex influences metastasis suppressor genes and cancer cell invasion.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- SUMOylation, a post-translational modification, is structurally similar to ubiquitination but has distinct biological outcomes.
- SUMOylation regulates the localization and stability of transcriptional cofactors and chromatin remodelers.
- Aberrant SUMOylation is implicated in tumorigenesis and metastasis due to its targets including oncogenes and tumor suppressor genes.
Purpose of the Study:
- To elucidate the role of SUMOylation in cancer metastasis.
- To highlight the novel functions of SUMOylation in chromatin remodeling complexes.
- To discuss the biological significance of SUMOylation in the context of cancer progression.
Main Methods:
- Review of existing literature on SUMOylation, chromatin remodeling, and cancer metastasis.
- Analysis of studies investigating the SUMOylation status of chromatin-remodeling complexes.
- Examination of the interplay between SUMOylation, metastasis suppressor genes, and cancer cell invasiveness.
Main Results:
- SUMOylation of the reptin chromatin-remodeling complex has been identified as a key regulator in metastasis.
- The SUMOylation status of reptin modulates the expression and activity of the KAI1 metastasis suppressor gene.
- SUMOylation influences the invasive potential of cancer cells, linking SUMO modification to metastatic activity.
Conclusions:
- SUMOylation plays a critical role in regulating cancer metastasis through chromatin remodeling pathways.
- Targeting SUMOylation pathways presents a potential therapeutic strategy for inhibiting cancer spread.
- Further research into SUMOylation's role in cancer is crucial for understanding and combating metastasis.
Related Concept Videos
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...